CHDI’s goal is to increase the understanding of Huntington’s disease (HD) and to hasten the development of therapies.We collaborate with academic and industrial scientists throughout the world.
This website highlights activities that may be of particular interest to people engaged in or contemplating HD research and provides information on targets, compounds, and research materials that HD researchers may find useful.
Please join our mailing list
KineMed, Isis and CHDI collaborate to advance therapeutic development for Huntington’s disease and develop novel biomarkers for pre-clinical and clinical use in drug development and therapeutic monitoring.
Upcoming Scientific Events
2013 World Congress on Huntington's Disease
September 15-18, 2013
Rio de Janerio, Brazil